Arrowstreet Capital, Limited Partnership Takeda Pharmaceutical CO LTD Transaction History
Arrowstreet Capital, Limited Partnership
- $121 Billion
- Q3 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 4,635,392 shares of TAK stock, worth $61.6 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
4,635,392
Previous 2,315,515
100.19%
Holding current value
$61.6 Million
Previous $30 Million
119.83%
% of portfolio
0.05%
Previous 0.03%
Shares
22 transactions
Others Institutions Holding TAK
# of Institutions
338Shares Held
73.8MCall Options Held
1.96MPut Options Held
165K-
Capital Research Global Investors Los Angeles, CA13.1MShares$174 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.35MShares$71.1 Million0.01% of portfolio
-
Mondrian Investment Partners LTD London, X05.09MShares$67.7 Million1.21% of portfolio
-
Goldman Sachs Group Inc New York, NY4.56MShares$60.6 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.41MShares$45.2 Million0.02% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $41.3B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...